1. Home
  2. VERX vs HRMY Comparison

VERX vs HRMY Comparison

Compare VERX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$12.20

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.42

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERX
HRMY
Founded
1978
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
VERX
HRMY
Price
$12.20
$39.42
Analyst Decision
Buy
Buy
Analyst Count
15
11
Target Price
$17.15
★ $47.64
AVG Volume (30 Days)
★ 1.2M
863.7K
Earning Date
11-02-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 7.97
EPS
N/A
★ 1.84
Revenue
$748,444,000.00
★ $868,453,000.00
Revenue This Year
$10.51
$18.74
Revenue Next Year
$10.51
$12.98
P/E Ratio
$302.25
★ $21.36
Revenue Growth
12.25
★ 21.51
52 Week Low
$10.21
$25.52
52 Week High
$26.54
$43.49

Technical Indicators

Market Signals
Indicator
VERX
HRMY
Relative Strength Index (RSI) 48.76 43.26
Support Level $12.16 $34.87
Resistance Level $13.56 $43.38
Average True Range (ATR) 0.49 1.32
MACD 0.05 -0.38
Stochastic Oscillator 71.00 11.24

Price Performance

Historical Comparison
VERX
HRMY

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: